🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

7,888 results for “1” Clear

  1. FLUCORTAC 50 microgrammes, comprimé sécable, Cellulose microcristalline 50 microgrammes

    H.A.C. Pharma

    Neurogenic Orthostatic Hypotension

    approved small molecule active

    1 trial

  2. FOSFOMYCIN

    The George Institute

    Uncomplicated urinary tract infection (uUTI)

    approved small molecule active

    1 trial

  3. Fenofibrate 145 mg

    United Therapeutics Europe Ltd

    Diabetic Retinopathy

    approved small molecule completed

    1 trial

  4. Fentanyl hameln 50 microgram/ml, oplossing voor injectie, Narcan Nasal Spray, Sufentanil Eurocept 5 microgram/ml, oplossing voor injectie, Zofran 4 Injectie, Naloxon HCl-hameln 0,4 mg/ml, oplossing voor injectie/infusie

    Disc Medicine

    healthy volunteers, opioid use disorder

    approved small molecule active

    1 trial

  5. Ferric Citrate 1 gram Oral Tablet

    Akebia Europe Limited

    Hyperphosphatemia

    approved small molecule completed

    1 trial

  6. Florbetapir F 18 (18F-AV-45)

    BRIGHT MINDS BIOSCIENCES INC.

    Postoperative Cognitive Dysfunction

    approved small molecule active

    1 trial

  7. Fluconazol Accord 50 mg capsules, hard, Diflucan I.V. 2 mg/ml, oplossing voor infusie, Diflucan 100 mg, capsule, hard, Diflucan 10 mg/ml, poeder voor orale suspensie

    Disc Medicine

    Fungal infection

    approved small molecule active

    1 trial

  8. Fludesoxiglucosa (18F)-Curium 185 MBq/ml, solución inyectable

    The George Institute

    Cardiovascular device infections

    approved small molecule active

    1 trial

  9. Fludex 1,5 mg, επικαλυμμένα με λεπτό υμένιο δισκία παρατεταμένης αποδέσμευσης., LUCIDEL 150 mg επικαλυμμένα με λεπτό υμένιο δισκία., Amlopen® 5mg καψάκια σκληρά, Inosamin 25mg, επικαλυμμένα με λεπτό υμένιο δισκία

    The George Institute

    Hypertension

    approved small molecule active

    1 trial

  10. Fluenz nasal spray suspension Influenza vaccine (live attenuated, nasal)

    Disc Medicine

    Influenza

    approved small molecule active

    1 trial

  11. Fluocinolone Acetonide Intravitreal Implant 0.18 mg

    ANI PHARMACEUTICALS INC

    Uveitis, Posterior

    approved small molecule active

    1 trial

  12. Foliumzuur Aurobindo 5 mg, tabletten, XELJANZ 5 mg film-coated tablets, METHOTREXAAT SANDOZ 2,5 MG, TABLETTEN, Methotrexaat Teva 20,0 mg, Oplossing voor injectie in een voorgevulde pen, Enbrel 50 mg solution for injection in pre-filled syringe, Methotrexaat Teva 25,0 mg, Oplossing voor injectie in een voorgevulde pen, Methotrexaat Teva 15 mg, Oplossing voor injectie in een voorgevulde pen

    Disc Medicine

    Psoriatic arthritis

    approved small molecule active

    1 trial

  13. Fostair 200 microgram/6 microgram per actuation pressurised inhalation solution, Trimbow 87 micrograms/5 micrograms/9 micrograms pressurised inhalation, solution

    Chiesi Farmaceutici S.p.A

    Asthma

    approved small molecule active

    1 trial

  14. GAVRETO ®(pralsetinib) capsules

    RIGEL PHARMACEUTICALS INC

    Patients with advanced or metastatic solid tumors

    approved small molecule active

    1 trial

  15. Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    The George Institute

    Evaluation of the reduction of HPV infectivity and transmission before and after vaccination with 9vHPV

    approved small molecule active

    1 trial

  16. Glivec 100 mg hard capsules, Tasigna 150 mg hard capsules

    Fondazione Telethon ETS

    Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)

    approved small molecule active

    1 trial

  17. Glucagon-like peptide-1 receptor agonist：Semaglutide

    The First People's Hospital of Lianyungang

    Type 2 Diabetes

    approved small molecule active

    1 trial

  18. Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53]

    Sarepta Therapeutics

    Duchenne Muscular Dystrophy

    approved small molecule terminated

    1 trial

  19. Group 1 Standard of Care

    Pacira Ireland Limited

    Retraction of Colostomy

    approved small molecule completed

    1 trial

  20. Guselkumab 1 mL PFS Placebo, Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL

    Janssen-Cilag International N.V.

    Psoriatic Arthritis

    approved small molecule active

    1 trial

  21. H1N1 influenza A Vaccine (PANFLU.1)

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  22. H1N1 influenza A Vaccine (Split virion), Inactivated

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  23. HALOPERIDOL, CLOZAPINE, TIAPRIDE, SERTINDOLE, PALIPERIDONE, OLANZAPINE, SULPIRIDE, ARIPIPRAZOLE, LURASIDONE, RISPERIDONE, AMISULPRIDE, CHLORPROMAZINE, PIMOZIDE, QUETIAPINE

    Disc Medicine

    HAMLETT compares regular treatment guidelines for patients in remission after a first episode of psychosis, namely continuation with antipsychotic medication for at least one year, with early dose reduction/discontinuation.

    approved small molecule active

    1 trial

  24. HTX-011

    Heron Therapeutics

    Analgesia

    approved small molecule completed

    6 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources